“STUDIES ON FIXED DOSE COMBINATION OF IBRUTINIB AND QUERCETIN SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS IN HUMAN CANCER CELL LINES”, Int. J. Pharm. Sci. Drug Res., vol. 15, no. 6, pp. 764–769, Nov. 2023, doi: 10.25004/IJPSDR.2023.150610.